Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases

1. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism

   Saade Abdalkareem Jasim, Maria Jade Catalan Opulencia, Andrés Alexis Ramírez‐Coronel +9

   Шарҳ мақолаGut microbiota and healthInternational Immunopharmacology20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.review-article.000010

2. The emerging microbiome‐based approaches to <scp>IBD</scp> therapy: From <scp>SCFAs</scp> to urolithin A

   Mohammad Rudiansyah, Saade Abdalkareem Jasim, Bakhadir S. Azizov +9

   Шарҳ мақолаInflammatory Bowel DiseaseJournal of Digestive Diseases20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.review-article.000031